🔗 Share this article

An underground economy for unlicensed slimming medications is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Experimental Drug Acquiring Traction Via Social Media

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Followers are encouraged to contact these accounts privately for supplier links, while also obtaining discount codes.

Active Commerce on Messaging Platforms

Additionally, a robust market exists on messaging services, where communities with numerous of participants share “before and after” photos, administration instructions and claims of next-day British shipping. Vendors market the substance there before redirecting buyers to WhatsApp for transactions.

Understanding Retatrutide

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Healthcare Professionals Express Concerns

However, physicians and pharmacists have warned that the distribution of what remains an unapproved drug in the UK is worrisome and could lead to individuals injecting products of unknown origin.

Several experts said the popularity for retatrutide could be linked to the increasing cost of approved slimming products such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unlicensed medication that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.

Some influencers attempt to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still breach pharmaceutical, marketing, and customer regulations, risking penalties, prosecution or imprisonment.

Service Response and Content Elimination

Based on TikTok, the platform has removed problematic material and banned associated hashtags and search suggestions. The company stated it was dedicated to keeping the platform secure and allocating resources in strengthening enforcement strategies.

Online Trading Operations

Research also discovered groups with up to 9,000 members marketing retatrutide using Telegram's integrated discovery tool, which functions like a public directory. Entering “retatrutide” instantly brings up groups with thousands of members, populated with photos of weight loss, glowing reviews and step-by-step guides for mixing or administering at residence.

Within minutes of joining one community, a seller posted contact information, where the majority of transactions occur. The vendor sent an instruction manual and guaranteed shipping within two days. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one asked about weight, medical conditions or past usage.

Item Information and Pricing

Inside these groups, posts show dark colored packages with Royal Mail labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with purified liquid, or ready-to-use injectors usually priced at £160 for 20mg. When questioned how long a pen should last, sellers give contradictory responses varying between a few weeks to “depends on your body”.

Platform Moderation and Security Actions

A spokesperson for Telegram said it regularly monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are injecting substances they cannot confirm. Although the research behind this drug is valid, these digital products may not include what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to current cost increases for approved weight-loss drugs such as Mounjaro. “With costs increasing, patients are using social media. But fake injections are highly dangerous. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she said.

Her team has already seen individuals injured by personal administration from unconfirmed suppliers. “We recognize the frustration, but buying from Telegram or WhatsApp is taking chances with your well-being,” said Wyllie. “These materials could be contaminated or improperly measured.”

Producer Statement

A representative from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, adding that any item “misleadingly claiming itself as a Lilly experimental substance not yet approved … may expose users to potentially significant medical dangers”.